News CombiGene AB

Equities

COMBI

SE0016101935

Market Closed - Nasdaq Stockholm Other stock markets 11:29:43 2024-04-18 am EDT			5-day change	1st Jan Change
3.85 ^SEK	0.00%		-3.51%	+43.12%

Mar. 13	CombiGene's Epilepsy Project CG01 Receives Patent in Two New Countries	CI
Feb. 21	Orphazyme A/S acquired an additional unknown minority stake in CombiGene AB (OM:COMBI).	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Notice of Annual General Meeting in CombiGene AB (publ)	Apr. 18	AQ
BioStock: CombiGene's CEO comments on the patent approvals in Australia and India	Mar. 20	AQ
CombiGene’s epilepsy project CG01 has been granted patent in two new countries	Mar. 13	AQ
CombiGene's Epilepsy Project CG01 Receives Patent in Two New Countries	Mar. 13	CI
BioStock: Comments from Orphazyme on the investment in CombiGene	Mar. 04	AQ
The Danish company Orphazyme has acquired 10% of the shares in CombiGene	Feb. 21	AQ
Orphazyme A/S acquired an additional unknown minority stake in CombiGene AB (OM:COMBI).	Feb. 20	CI
Year-end report January-December 2023 CombiGene AB (Publ)	Feb. 16	AQ
CombiGene AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 16	CI
BioStock: CombiGene comments on the discontinued CGT2 project	Feb. 02	AQ
CombiGene discontinues the preclinical development of the lipodystrophy project CGT2	Feb. 01	AQ
CombiGene: "We continue to believe in the epilepsy project CG01"	Jan. 16	AQ
CombiGene has regained the global rights to the epilepsy project CG01	Jan. 13	AQ
BioStock: CombiGene comments on Eurostars funding	Dec. 22	AQ
Eurostars contributes SEK 8,7 million to the financing of the COZY01 pain project	Dec. 20	AQ
New issue of CombiGenes, no 5 2023	Nov. 27	AQ
BioStock: CombiGene focuses on the pain project	Nov. 15	AQ
Interim report January – September 2023 for CombiGene AB (publ)	Nov. 10	AQ
CombiGene AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 10	CI
CombiGene Taps Charles River Laboratories as Clinical Research Partner for Pain Project	Nov. 01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News CombiGene AB

Equities

COMBI

SE0016101935

Summary

Filters